Zinc supplementation in very low birth weight neonates

Phase 3

Recruiting

• Conditions: Morbidity in very low birth weight neonates; Intraventricular hemorrhage; Retinopathy of prematurity; Diet and Nutrition - Other diet and nutrition disorders; sepsis; Necrotizing enterocolitis; Bronchopulmonary dysplasia; Reproductive Health and Childbirth - Complications of newborn; Oral and Gastrointestinal - Normal oral and gastrointestinal development and function

• Registration Number: ACTRN12612000823875
• Lead Sponsor: V.Betania” Evangelic Hospital of Naples

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-08-06
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

Newborns with birth weight 401-1500 g or gestational age 24-32 weeks, consecutively observed in Neonatal Intensive Care Units

Exclusion Criteria

congenital or maternal infections, immunodeficiency, malformations, syndrome, genetic defects, evidence of infections and NEC before enrolment, critically ill condition (blood pH < 6.8, or hypoxia with persistent bradycardia for at least 1 hour), and hospitalization less than 1 week

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The morbidity of very low birth weight newborns treated with zinc. Morbidity was defined by the presence of at least one of the following conditions: BPD, IVH, NEC, sepsis, and ROP[Morbidity of neonates during hospitalization]

Secondary Outcome Measures

Name	Time	Method
mortality[Mortality of neonates during hospitalization]